| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 08/12/2009 | CN101503702A Mycobacteria differential expression system, and preparation and uses thereof |
| 08/12/2009 | CN101503694A Rearranged bacterial virus bacteriolysis gene, perforating vector thereof and use in vaccine preparation |
| 08/12/2009 | CN101503686A DNA sequence for reinforcing bacterial virus bacteriolysis gene perforating efficiency and use thereof |
| 08/12/2009 | CN101503475A Fusion protein of anthrax lethal factor domain (LFn) and anthrax edema factor domain (EFn) and use thereof |
| 08/12/2009 | CN101503473A Targeted polypeptide for diagnosing and treating lung cancer in vivo and in vitro and use thereof |
| 08/12/2009 | CN101503472A Human source neutralizing antibody specific against botulinum neurotoxin type A and use thereof |
| 08/12/2009 | CN101502674A Medical device with coating that promotes endothelial cell adherence and differentiation |
| 08/12/2009 | CN101502657A Method for constructing phage vector vaccine fused with gp350 protein of EB virus |
| 08/12/2009 | CN101502652A Chickenpox, herpes zoster human immunoglobulin and preparation method thereof |
| 08/12/2009 | CN101502651A Hydrophobia, tetanus double-titer human immunoglobulin and preparation method thereof |
| 08/12/2009 | CN101502650A Hepatitis B nucleic acid vaccine with optimized codon |
| 08/12/2009 | CN101502649A Liposome influenza vaccine |
| 08/12/2009 | CN101502648A 疫苗 Vaccine |
| 08/12/2009 | CN100526876C Unmethylated CpG dinucleotide content detection method |
| 08/12/2009 | CN100526452C Colloidal gold immune chromatography fast differential diagnosis kit of chicken avian influenza vaccine immunity and virus strain infection and application |
| 08/12/2009 | CN100526331C CTL epitopes from EBV |
| 08/11/2009 | US7572904 Nucleotide sequences coding viral genome for use in developing vaccine to prevent respiratory system infections; genetic vaccines |
| 08/11/2009 | US7572895 Transferrin receptor antibodies |
| 08/11/2009 | US7572892 Cytokine zalpha11 ligand fusion proteins |
| 08/11/2009 | US7572891 Kidney-specific tumor vaccine directed against kidney tumor antigen G-250 |
| 08/11/2009 | US7572886 Death associated proteins, and THAP1 and PAR4 pathways in apoptosis control |
| 08/11/2009 | US7572882 Inducing cellular immune responses to human papillomavirus using peptide and nucleic acid compositions |
| 08/11/2009 | US7572768 Methods for identifying compounds for regulating muscle mass or function using corticotropin releasing factor receptors |
| 08/11/2009 | US7572589 Diagnosis and treatment of infectious diseases through indel-differentiated proteins |
| 08/11/2009 | US7572466 Oral immunology using plant product containing a non-enteric pathogen antigen |
| 08/11/2009 | US7572457 Immunoglobulins; vaccines |
| 08/11/2009 | US7572456 Comprising three VH complementary determining regions (CDRs) and three VL CDRs; plasmids; hybridomas |
| 08/11/2009 | US7572455 bovine viral diarrhea virus; point mutations; glycoproteins; RNAse inhibition |
| 08/11/2009 | US7572454 From Canine Distemper Virus; vaccines; luteinizing hormone releasing hormone |
| 08/11/2009 | US7572453 Envelope glycoproteins; capsids; immunogens |
| 08/11/2009 | US7572451 Gastric inhibitory polypeptide (GIP) antigen arrays and uses thereof |
| 08/11/2009 | US7572450 Composition for preventing cell death and/or tissue necrosis resulting from contact with neural thread proteins |
| 08/11/2009 | US7572449 Vaccine against Yersinia comprising one or two antibodies, one specific for Yersinia pestis F1-antigen and the other one for Yersinia pestis V-antigen |
| 08/11/2009 | US7572448 antibody, immunoconjugate and duramycin-based compositions; bind and inhibit anionic phospholipids and aminophospholipids, for use in the safe and effective treatment of cancer, viral infections and related diseases |
| 08/11/2009 | US7572447 Methods and compositions for selective modulation of vascularization |
| 08/11/2009 | US7572446 Antagonists of HMG1 for treating inflammatory conditions |
| 08/11/2009 | US7572445 Arterivirus (RNA enveloped virus); polypeptides with sensitivity and specificity; decreasing the incidence of false positives in a diagnostic assay |
| 08/11/2009 | US7572444 Binding proteins specific for human matriptase |
| 08/11/2009 | US7572443 Anti-Platelet endothelial cell adhesion molecule (PECAM); monoclonal antibodies; kits |
| 08/11/2009 | US7572442 Selected antibody compositions for binding to aminophospholipids |
| 08/11/2009 | US7572441 Media and method for treating pathological syndrome |
| 08/11/2009 | US7572437 Long acting human interferon analogs |
| 08/11/2009 | US7572436 Thionin as an antineoplastic and immunostimulant |
| 08/11/2009 | CA2348732C Human h37 proteins and cdnas encoding the same |
| 08/11/2009 | CA2271248C Use of a notch ligand in immunotherapy |
| 08/11/2009 | CA2241572C Apo-2 ligand |
| 08/11/2009 | CA2236699C Immunity against actinobacillus pleuropneumoniae's rtx toxins apx |
| 08/11/2009 | CA2224404C Cell volume-regulated human kinase h-sgk |
| 08/11/2009 | CA2192940C Nucleotide sequences of pestivirus strains, polypeptides encoded by these sequences and use thereof for diagnosis and prevention of pestivirus infections |
| 08/08/2009 | CA2653300A1 Polyvalent vaccine against salmonid alphavirus infections |
| 08/06/2009 | WO2009097596A1 Compositions and methods for the treatment of chronic infections |
| 08/06/2009 | WO2009097397A2 Metalloproteinase binding proteins |
| 08/06/2009 | WO2009097325A1 Stabilized angiopoietin-2 antibodies and uses thereof |
| 08/06/2009 | WO2009097291A2 Canine influenza vaccines |
| 08/06/2009 | WO2009097155A1 Compositions and methods for treating diabetes using lisofylline and islet neogenesis associated peptide |
| 08/06/2009 | WO2009097128A1 Membrane transporter napi2b (slc34a2) epitope for antibody therapy, antibodies directed thereto, and target for cancer therapy |
| 08/06/2009 | WO2009097120A1 Methods using immunomodulatory compounds for modulating level of cd59 |
| 08/06/2009 | WO2009097095A2 Methods for treating hematopoietic malignancies |
| 08/06/2009 | WO2009096162A1 Composition for neutralizing botulinus toxin type-a, and human anti-botulinus toxin type-a antibody |
| 08/06/2009 | WO2009095857A1 Multimeric proteins able to induce an antibody response against the beta-amyloid and use thereof |
| 08/06/2009 | WO2009095796A2 Tapasin augmentation for enhanced immune response |
| 08/06/2009 | WO2009095518A1 Heterologous protection against pasteurella multocida provided by p. multocida fur cells and the outer-membrane protein extracts thereof |
| 08/06/2009 | WO2009095489A2 Improved amino acid sequences directed against il-6r and polypeptides comprising the same for the treatment of diseases and disorders associated with il-6-mediated signalling |
| 08/06/2009 | WO2009095478A1 Antibodies against human cd39 and use thereof for inhibiting t regulatory cells activity |
| 08/06/2009 | WO2009095226A2 NUCLEIC ACIDS COMPRISING FORMULA (NuGlXmGnNv)a AND DERIVATIVES THEREOF AS AN IMMUNOSTIMULATING AGENTS /ADJUVANTS |
| 08/06/2009 | WO2009094752A1 An anti-cancer cytotoxic monoclonal antibody |
| 08/06/2009 | WO2009094751A1 An anti-cancer cytotoxic monoclonal antibody |
| 08/06/2009 | WO2009094730A1 Vaccine compositions |
| 08/06/2009 | WO2009094726A1 Plasmodial polynucleotides, proteins and uses thereof |
| 08/06/2009 | WO2009094717A2 A method of inducing tolerance to an allergen |
| 08/06/2009 | WO2009073146A3 Use of immunomodulatory compounds for the treatment of transverse myelitis, multiple sclerosis, and other disorders |
| 08/06/2009 | WO2009055074A8 Erbb2 binding proteins and use thereof |
| 08/06/2009 | WO2009051840A3 Compositions and methods for reducing hepatotoxicity associated with drug administration |
| 08/06/2009 | WO2009048769A3 Vaccinia virus h3l and b5r specific monoclonal antibodies and methods of making and using same |
| 08/06/2009 | WO2009047002A3 Products and their use for the diagnosis, prevention, and/or care of human and/or animal pathologies characterised by the anomalous deposition of b-amyloid and/or amyloid-like substance in human and/or animal organs and tissues, and screening method for determining the risk of such pathologies |
| 08/06/2009 | WO2009019657A3 Means for diagnosis and treatment of rheumatoid arthritis |
| 08/06/2009 | WO2008149238A3 Formulation of meningitis vaccines |
| 08/06/2009 | WO2008132500A3 Chkl inhibitors with b cell depleting antibodies for the treatment of hematologic malignancies |
| 08/06/2009 | WO2008109852A8 Compositions and methods for the prevention and treatment of autoimmune conditions |
| 08/06/2009 | WO2008095015A8 Method of treating recurrent tumors |
| 08/06/2009 | WO2008064031A9 Potent activation of antigen presenting cells by the hepatitis a virus cellular receptor 1 and its role in the regulation of immune responses |
| 08/06/2009 | WO2008052165A8 Method for treating pathological pulmonary conditions and bleomycin associated pulmonary fibrosis |
| 08/06/2009 | WO2008038127A8 Junctional adhesion molecule-c (jam-c) binding compounds and methods of their use |
| 08/06/2009 | WO2008036675A8 Compositions and methods of enhancing immune responses |
| 08/06/2009 | WO2008016976A8 Vaccines and methods for controlling adiposity |
| 08/06/2009 | WO2007149875A8 Compositions and methods for treating, preventing and/or reversing type-1 diabetes |
| 08/06/2009 | US20090198044 Anti-psgl-1 antibodies |
| 08/06/2009 | US20090197319 Virus-Like Particle Containing A Dengue Recombinant Replicon |
| 08/06/2009 | US20090196928 Biocompatible hydrogel compositions |
| 08/06/2009 | US20090196915 Composition and methods of making and using influenza proteins |
| 08/06/2009 | US20090196888 Nucleic acids encoding recombinant 56 and 82 kDa antigents from gametocytes of Eimeria maxima and their uses |
| 08/06/2009 | US20090196887 Immunogenic Compositions for Activating Gamma Delta T Cells |
| 08/06/2009 | US20090196886 Vaccine against nicotine addiction |
| 08/06/2009 | US20090196884 Malaria Vaccines |
| 08/06/2009 | US20090196883 synthetic P. vivax circumsporozoite protein useful as a diagnostic reagent, for antibody production, and as a vaccine protective against infection with any strain of P. vivax; malaria vaccine |
| 08/06/2009 | US20090196882 Methods of producing antibodies to zalpha11 cytokine receptors |
| 08/06/2009 | US20090196881 DNA vaccine against north american spring viremia of carp virus |
| 08/06/2009 | US20090196880 Cancer treatment using humanized antibodies that bind to EphB4 |
| 08/06/2009 | US20090196879 B-cell depleting agents, like anti-CD20 antibodies or fragments thereof for the treatment of chronic fatigue syndrome |
| 08/06/2009 | US20090196878 Intestinal epithelial glucose sensor |